Client Portal
Physician Portal
Spherix Global InsightsSpherix Global Insights
Menu

Expertise

  • Dermatology
  • Gastroenterology
  • Nephrology
  • Neurology
  • Ophthalmology
  • Rheumatology

Spherix

  • Services
  • Physicians
  • About
  • Media
  • Connect
  • Careers

Spherix 2023 Publications

  • Privacy Policy
  • Client Portal
  • Physician Portal
Spherix Global Insights

Back to All Media

News

September 21, 2023

NewsPress Release

Spherix Global Insights Announces New Leadership to Drive Growth and Innovation

Pharmaceutical industry veteran Dan Barton to serve as Chief Executive Officer. Exton PA, September 21, 2023 — Spherix Global Insights,...

August 31, 2023

DermatologyNewsPress Release

With Little Remaining Unmet Need for Injectable Biologics for the Treatment of Plaque Psoriasis, US Dermatologists Report the Future is Oral, According to Spherix Global Insights

Despite the increased efficacy of BMS’ Sotyktu over Amgen’s Otezla, dermatologists continue to express a desire for additional oral agents...

August 17, 2023

NeurologyNewsPress Release

Another Medicine to Stop Migraine in its Tracks – Zavzpret™ is Now Available, but Where will Neurologists use it?

Will Pfizer’s marketing power help Zavzpret™ rapidly gain share in the crowded migraine market? Exton, PA., August 17, 2023 –In February...

August 10, 2023

NeurologyNewsPress Release

What’s on Your Must-Read List? If You Work in Pharma, Add Spherix Global Insights’ Generalized Myasthenia Gravis Patient Chart Audit to that List

US neurologists in Spherix’s in-house physician network complete a patient chart audit of over 600 patients with gMG. Exton, PA,...

August 01, 2023

NeurologyNewsPress Release

Breaking Into a Saturated Relapsing Remitting Multiple Sclerosis Market: Where Should Developers Focus?

According to Spherix Global Insights, U.S. neurologists are largely satisfied with current treatment choices in the RMS market, but opportunities remain....

July 28, 2023

NewsOphthalmologyPress Release

First-to-Market Edge for Apellis’s Syfovre in Geographic Atrophy Diminished in the Face of an Unexpected Safety Signal

Prospects for Syfovre uptake and trust in Apellis take a plunge following reports of intraocular inflammation, according to Spherix Global...

July 27, 2023

NewsPress ReleaseRheumatology

Market Access Issues Hindering Specialists’ Use of Advanced Systemics in Lupus Nephritis

According to Spherix Global Insights, US Rheumatologists are taking increasing ownership over lupus nephritis (LN) patient management, yet they are...

July 20, 2023

NephrologyNewsPress Release

Akebia’s Vafseo (vadadustat) Poised to Make Waves for GSK’s Jesduvroq and FibroGen/Astellas’ Evrenzo

According to Spherix Global Insights and EU5 nephrologists are anticipating a more dynamic and competitive HIF-PH inhibitor market Exton, PA,...

July 19, 2023

GastroenterologyNewsPress Release

A Call for Help from Physician Specialists on the Frontline Treating MASLD/MASH

Spherix Global Insights finds gastroenterologist and hepatologist capacity is being stretched to the limit by increasing demand from MASLD/MASH patients...

July 11, 2023

DermatologyNewsPress Release

Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata

After early adoption, overall use of Olumiant in alopecia areata is beginning to level-off, according to Spherix Global Insights Exton,...

May 23, 2023

GastroenterologyNewsPress Release

Riding the Early Adoption Wave Created by Ferring’s Rebyota, Aimmune’s Vowst, is Set to Provide a New Fecal Microbiota Transplant (FMT) Option for Patients Struggling with Recurrent Clostridioides Difficile, According to Spherix Global Insights

Ferring Pharmaceutical’s achieved an innovative milestone in C.Diff treatment when it launched Rebyota, the first FDA approved Fecal Microbiota Transplant...

May 22, 2023

GastroenterologyNewsPress Release

The Rising NAFLD/NASH Epidemic Coupled with High Patient Need Offers Opportunities for Pharmaceutical Manufacturers to Capitalize Across Various Disease Stages, According to Spherix Global Insights

New Spherix research highlights existing need for innovation in this underserved population EXTON, Pa., May 22, 2023 — The non-alcoholic...

1 2 Next »
Spherix Global Insights
  • Expertise
    • Dermatology
    • Gastroenterology
    • Nephrology
    • Neurology
    • Ophthalmology
    • Rheumatology
  • Services
  • About
  • Connect
  • Media Center

760 Constitution Drive
Suite #204
EXTON,PA 19341

Spherix Global Insights

Privacy Policy

Company Spotlight
Introducing Spherix’s Client Portal

The Spherix Client Portal represents an innovative, well-designed channel for clients to interact with Spherix data and insights, deepening Spherix’s role in expertly providing key answers to important business questions. The portal allows Spherix clients to easily search and find all their subscribed data and insights from over the past 12 months, as well as provides a means for both clients and other interested individuals to see the full spectrum of what Spherix has to offer across therapeutic areas. Innovative portal functions and features help clients easily integrate relevant and actionable intelligence into internal deliverables for seamless dissemination.

CLICK HERE TO REGISTER OR ACCESS YOUR PORTAL ACCOUNT